0M, trading at S$0.22 on the SES. This SniperIQ fundamentals page covers Medinex's valuation (P/E 9.7x, P/B 1.7x), profitability (net margin 15.9%), revenue (S

What is Medinex's P/E ratio?

Medinex's trailing twelve-month P/E ratio is 9.7x, with a price-to-book (P/B) of 1.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Medinex?

Medinex runs a net profit margin of 15.9%, a gross margin of 35.1%, and an operating margin of 19.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Medinex generate?

Medinex reported revenue of S

Does Medinex pay a dividend?

Medinex offers a trailing dividend yield of about 7.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Medinex financially healthy?

Medinex carries a debt-to-equity ratio of 0.06x and a current ratio of 3.50x, with a market beta of 0.13. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Medinex a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Medinex (OTX) the key facts are: market cap S

0M, P/E 9.7x, revenue S

Track Medinex's full fundamentals live

Get Medinex's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.